PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Feb-2023 Merck and AstraZeneca Present Final Results of Key Secondary Overall Survival Endpoint From Phase 3 PROpel Trial at 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium Businesswire
16-Feb-2023 Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Businesswire
16-Feb-2023 Pendulum Therapeutics Launches Metabolic Daily, a Unique Probiotic Blend that Optimizes Metabolism and Supports a Healthy Weight Businesswire
16-Feb-2023 ImmunityBio to Present ‘Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15R⍺Fc superagonist N-803 plus BCG’ at ASCO GU Businesswire
16-Feb-2023 CurvaFix Launches Smaller-diameter CurvaFix® IM Implant Businesswire
16-Feb-2023 Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models Businesswire
16-Feb-2023 Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs Businesswire
16-Feb-2023 GE HealthCare Leaders to Present at March Investor Conferences Businesswire
16-Feb-2023 GlycoMimetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Businesswire
16-Feb-2023 Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company Businesswire
16-Feb-2023 Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022 Businesswire
16-Feb-2023 Aldeyra Therapeutics Advances Investigational Oral RASP Modulator ADX‑629 Into New Phase 2 Systemic Disease Trials Businesswire
16-Feb-2023 Labcorp Announces 2022 Fourth Quarter and Full-Year Results Businesswire
16-Feb-2023 Aura Biosciences Announces Positive Interim Phase 2 Safety and Efficacy Data of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma with Suprachoroidal Administration Businesswire
16-Feb-2023 Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders Businesswire
16-Feb-2023 Ryne Biotechnologyがカリフォルニア州再生医療機構より400万ドルの助成金を受領 Businesswire
16-Feb-2023 KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology Businesswire
16-Feb-2023 Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines Businesswire
16-Feb-2023 M2GEN and Zephyr AI Announce Partnership to Better Identify Treatments and Cures for Patients with Cancer Businesswire
16-Feb-2023 VUV Analytics Announces $20 Million Financing Newswire